跳至主要内容
临床试验/NCT02313116
NCT02313116暂停不适用

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

Diagnostic Photonics, Inc.1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
入组人数
50
试验地点
1
主要终点
Patients With All Positive/Close Margins Correctly Identified With the Device

研究概览

简要总结

This intraoperative study is a prospective study analyzing specimens from fifty subjects. Patients scheduled to undergo breast-conserving surgery will be recruited in accordance with the inclusion and exclusion criteria. The study period per subject is the time it takes to assess the ex vivo breast tissue sample using the study device. Image review will be conducted during surgery and compared to the margin status findings in the post-operative pathology report.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women 18 years of age or older
  • Signed informed consent form
  • Women who have been histologically diagnosed with carcinoma of the breast prior to surgery
  • Patients planning breast preservation and undergoing lumpectomy (partial mastectomy) procedure

排除标准

  • Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)
  • Neoadjuvant systemic therapy
  • All T4 tumors
  • Previous radiation in the operated breast
  • Prior surgical procedure in the same quadrant
  • Implants in the operated breast
  • Participating in any other investigational study for either drug or device which can influence collection of valid data under this study

结局指标

主要结局

Patients With All Positive/Close Margins Correctly Identified With the Device

时间窗: 1 week after surgery

Number of Margins With False Positive Device Readings

时间窗: 1 week after surgery

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验